Clinical Trial Update: Autologous Adipose-Derived Stromal Cells Delivered Into the Corpus Cavernous in Patients With Erectile Dysfunction [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial using autologous adipose-derived stromal cells delivered into the corpus cavernosum for erectile dysfunction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• Autologous adipose-derived stromal cells (adipose-derived stromal cells)

Snippet

Sponsor: Ageless Regenerative Institute | Conditions: Erectile Dysfunction | Phase 1, Phase 2 | Status: WITHDRAWN